Orum Therapeutics Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-41,969	-5,740	68,217	-63,319
Depreciation & Amortization	3,297	2,868	1,771	1,290
Other Amortization	-	-	824.72	799.07
Loss (Gain) From Sale of Assets	4.13	-	-205.25	-
Loss (Gain) From Sale of Investments	-2,906	-799.27	809.55	52.63
Stock-Based Compensation	867.79	781.94	1,170	786.5
Other Operating Activities	-5,144	-972.54	22,514	21,534
Change in Accounts Receivable	1.92	-1.87	-0.6	-
Change in Accounts Payable	-	-3.45	-850.67	802.53
Change in Other Net Operating Assets	9,860	-7,415	-5.32	-3,037
Operating Cash Flow	-35,989	-11,282	94,244	-41,092
Capital Expenditures	-696.27	-1,264	-1,126	-796.13
Sale of Property, Plant & Equipment	-	-	47	-
Sale (Purchase) of Real Estate	-	-	1,796	-
Investment in Securities	-27,628	-97,197	262.76	27,758
Other Investing Activities	-0	-0	-3,405	-265.99
Investing Cash Flow	-28,324	-98,460	-2,426	26,701
Long-Term Debt Repaid	-887.52	-1,017	-2,281	-1,394
Net Debt Issued (Repaid)	-887.52	-1,017	-2,281	-1,394
Issuance of Common Stock	49,567	178.5	-	-
Other Financing Activities	-0	-	-145.8	-
Financing Cash Flow	48,679	-838.32	23,573	-1,394
Foreign Exchange Rate Adjustments	-1.52	3,622	-8.15	-81.88
Net Cash Flow	-15,635	-106,959	115,383	-15,866
Free Cash Flow	-36,685	-12,545	93,117	-41,888
Free Cash Flow Margin	-155680.70%	-60.01%	68.76%	-55173.99%
Free Cash Flow Per Share	-1763.05	-926.66	6184.75	-9106.02
Cash Interest Paid	1,875	1,788	813.28	75.37
Cash Income Tax Paid	478.59	-449.93	329.15	18.55
Levered Free Cash Flow	-19,893	-10,472	59,189	-
Unlevered Free Cash Flow	-18,717	-9,351	59,704	-
Change in Working Capital	9,862	-7,420	-856.59	-2,235

Source: S&P Global Market Intelligence. Standard template. Financial Sources.